Avenir Corporation’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.16M Hold
74,865
– – 0.27% 28
2026
Q2
$1.61M Sell
74,865
-1,500
-2% -$23K 0.2% 33
2026
Q1
$1.06M Hold
76,365
– – 0.13% 39
2025
Q4
$1.24M Hold
76,365
– – 0.13% 36
2025
Q3
$1.14M Hold
76,365
– – 0.12% 38
2025
Q2
$890K Hold
76,365
– – 0.09% 43
2025
Q1
$567K Hold
76,365
– – 0.06% 48
2024
Q4
$458K Hold
76,365
– – 0.05% 51
2024
Q3
$391K Hold
76,365
– – 0.04% 54
2024
Q2
$276K Buy
76,365
+10,000
+15% +$31.7K 0.03% 60
2024
Q1
$213K Hold
66,365
– – 0.02% 64
2023
Q4
$325K Buy
66,365
+35,800
+117% +$163K 0.03% 56
2023
Q3
$167K Hold
30,565
– – 0.02% 59
2023
Q2
$205K Sell
30,565
-85
-0.3% -$632 0.02% 59
2023
Q1
$271K Hold
30,650
– – 0.03% 55
2022
Q4
$234K Hold
30,650
– – 0.02% 59
2022
Q3
$218K Sell
30,650
-23,450
-43% -$221K 0.02% 57
2022
Q2
$438K Buy
54,100
+25,100
+87% +$221K 0.04% 48
2022
Q1
$403K Buy
29,000
+1,000
+4% +$15.7K 0.03% 51
2021
Q4
$786K Hold
28,000
– – 0.06% 44
2021
Q3
$952K Hold
28,000
– – 0.08% 45
2021
Q2
$1.14M Hold
28,000
– – 0.09% 43
2021
Q1
$1.13M Hold
28,000
– – 0.1% 45
2020
Q4
$1.66M Hold
28,000
– – 0.16% 37
2020
Q3
$1.36M Hold
28,000
– – 0.14% 39
2020
Q2
$1.36M Buy
+28,000
New +$1.02M 0.15% 39

Other funds holding ADPT

Avenir Corporation's ADPT Position: Q3 2026 in Review

Avenir Corporation held its Adaptive Biotechnologies (ADPT) position steady in Q3 2026 at 74,865 shares worth $2.16M. The position accounts for 0.27% of the portfolio, ranked #28.

Avenir Corporation first reported a position in ADPT in Q2 2020 and has held it in 26 quarters since. 331 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.

  • Avenir Corporation held 74,865 shares of Adaptive Biotechnologies worth $2.16M as of Q3 2026.
  • Avenir Corporation left its Adaptive Biotechnologies share count unchanged in Q3 2026.
  • Adaptive Biotechnologies made up 0.27% of Avenir Corporation's portfolio in Q3 2026, its #28 holding.
  • Avenir Corporation first reported a position in Adaptive Biotechnologies in Q2 2020 and has held it in 26 quarters since.
  • 331 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.

Based on Avenir Corporation's 13F filing for Q3 2026, filed 13 Nov 2026.